OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients and supplements. Its core focus is on the prevention and management of chronic lifestyle diseases, including obesity, hypercholesterolemia (high cholesterol), and diabetes. The company's approach is underpinned by scientific research and human clinical studies, delivering proprietary ingredients like SlimBiome® and LPLDL® as well as white-label product solutions to its commercial partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 08:00
Director's Dealing
Director/PDMR Shareholding
English 33.8 KB
2025-09-24 13:28
Director's Dealing
Director/PDMR Shareholding
English 43.8 KB
2025-09-16 08:00
Interim Report
Half-year Report
English 230.4 KB
2025-08-21 08:00
Delisting Announcement
Admission to Trading on the OTCQB Venture Market
English 14.4 KB
2025-08-20 08:00
Regulatory News Service
Agreement with Weight Management Company
English 15.1 KB
2025-08-14 08:00
Regulatory News Service
Launch of SlimBiome in leading US brand
English 17.0 KB
2025-08-06 17:08
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 13.9 KB
2025-08-06 08:00
Share Issue/Capital Change
Issue of Options
English 31.2 KB
2025-07-28 08:00
Earnings Release
Trading update
English 19.1 KB
2025-06-30 08:00
Earnings Release
Final Results
English 544.3 KB
2025-06-30 08:00
Regulatory News Service
Change of Broker
English 11.6 KB
2025-06-11 08:00
Environmental & Social Information
SlimBiome® study in European Journal of Nutrition
English 28.0 KB
2025-05-23 08:00
Share Issue/Capital Change
Placing and Issue of Warrants
English 20.6 KB
2025-03-18 08:00
Business and Financial Review
Commercial Update
English 35.7 KB
2025-02-18 08:00
Regulatory News Service
Launch of Daily Nouri FeelFull product in America
English 18.4 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany NMI
Alten Logo
Global engineering and IT consulting for digital transformation in industry and telecom sectors.
France ATE
Amoéba Logo
Develops amoeba-based natural fungicides for agriculture and active ingredients for cosmetics.
France ALMIB
APTAMER GROUP PLC Logo
Develops custom aptamer-based binders as antibody alternatives for life science applications.
United Kingdom APTA
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel ARAN
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP

Talk to a Data Expert

Have a question? We'll get back to you promptly.